TATVA CHINTAN PHARMA CHEM
Back to Balance Sheet
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-11 Cr | ₹-10 Cr | ₹-11 Cr | ₹5.06 Cr | ₹31 Cr |
What is the latest Total Non-Current Liabilities ratio of TATVA CHINTAN PHARMA CHEM ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-10 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹5.06 Cr |
| Mar2021 | ₹31 Cr |
How is Total Non-Current Liabilities of TATVA CHINTAN PHARMA CHEM Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-10 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹5.06 Cr | -83.58 | |
| Mar2021 | ₹31 Cr | - | |
Compare Total Non-Current Liabilities of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹3,068.1 Cr | 2.8% | 13.6% | 82.4% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹142,718.0 Cr | 0.7% | 7.1% | -6.5% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹142,471.0 Cr | 4.4% | 19.7% | 24.9% | Stock Analytics | |
| SRF | ₹75,349.7 Cr | 1.9% | 2.5% | -16.6% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹36,392.8 Cr | -1.3% | 4.7% | -17.7% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹33,537.3 Cr | 7.4% | 21.1% | -16.3% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | 2.8% |
13.6% |
82.4% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses